FIELD: pharmacology.
SUBSTANCE: Alzheimer's and a method for Alzheimer's disease treatment. The pharmaceutical composition contains 0.05 to 100 international units (IU) of insulin and 0.05 to 10% of dicholine succinate. Preferably, the pharmaceutical composition is prepared in the form of intranasal spray.
EFFECT: improved cognitive function in a mammal.
7 cl, 3 tbl, 3 ex
Authors
Dates
2017-05-18—Published
2016-09-27—Filed